Plasma vitamin D biomarkers and leukocyte telomere length.

Vitamin D may reduce telomere shortening through anti-inflammatory and anti-cell proliferation mechanisms. In the present study, we examined the association between vitamin D and relative leukocyte telomere length by using both plasma 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D) biomarkers. Vitamin D biomarker levels and leukocyte telomere length were measured using plasma samples collected in 1989-1990 from participants of the Nurses' Health Study, a study of nurses from 11 US states. In total, 1,424 participants had their 25(OH)D levels assessed and 837 had their 1,25(OH)2D levels assessed. Genotyping was performed on 480 participants on 12 single nucleotide polymorphisms in vitamin D-related genes. Linear and logistic regression models were used. Higher 25(OH)D levels were significantly associated with longer telomere length (P for trend = 0.05), and the odds ratio increased from 1.07 (P = 0.65) when comparing the second lowest quartile of 25(OH)D with the lowest to 1.59 (P = 0.01) when comparing the highest quartile with the lowest. Vitamin D-related single nucleotide polymorphisms and 1,25(OH)2D levels were not significantly associated with telomere length. Total calcium intake significantly modified the association between 25(OH)D and telomere length (P for interaction = 0.05). Higher plasma 25(OH)D levels may be associated with longer telomeres, and this association may be modified by calcium intake.

[1]  H. Morris,et al.  Autocrine and paracrine actions of vitamin d. , 2010, The Clinical biochemist. Reviews.

[2]  J. Buring,et al.  Telomere length and genetic analyses in population‐based studies of endometrial cancer risk , 2010, Cancer.

[3]  M. Bown,et al.  Telomere length dynamics in vascular disease: a review. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  William Wheeler,et al.  Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.

[5]  B. Ponder,et al.  Telomere length in prospective and retrospective cancer case-control studies. , 2010, Cancer research.

[6]  J. Reichrath,et al.  The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. , 2009, Anticancer research.

[7]  D. Hunter,et al.  A Prospective Study of Relative Telomere Length and Postmenopausal Breast Cancer Risk , 2009, Cancer Epidemiology Biomarkers & Prevention.

[8]  D. Hunter,et al.  A prospective study of telomere length and the risk of skin cancer. , 2009, The Journal of investigative dermatology.

[9]  H. Moonen,et al.  Telomere length assessment: biomarker of chronic oxidative stress? , 2008, Free radical biology & medicine.

[10]  T. Spector,et al.  Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. , 2007, The American journal of clinical nutrition.

[11]  D. Trump,et al.  Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.

[12]  H. Cross.  Extrarenal vitamin D hydroxylase expression and activity in normal and malignant cells: modification of expression by epigenetic mechanisms and dietary substances. , 2007, Nutrition reviews.

[13]  W. Willett,et al.  Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. , 2007, American journal of epidemiology.

[14]  D. Medeiros,et al.  Dietary Reference Intakes: the Essential Guide to Nutrient Requirements edited by JJ Otten, JP Hellwig, and LD Meyers, 2006, 560 pages, hardcover, $44.96. The National Academies Press, Washington, DC. , 2007 .

[15]  S. Nagpal,et al.  Noncalcemic actions of vitamin D receptor ligands. , 2005, Endocrine reviews.

[16]  H. DeLuca,et al.  All-trans retinoic acid antagonizes the action of calciferol and its active metabolite, 1,25-dihydroxycholecalciferol, in rats. , 2005, The Journal of nutrition.

[17]  D. Rao,et al.  Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. , 2004, Clinical biochemistry.

[18]  Timothy R Church,et al.  Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. , 2003, Journal of the National Cancer Institute.

[19]  R. Cawthon.  Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[20]  W. Willett,et al.  Calcium intake and risk of colon cancer in women and men. , 2002, Journal of the National Cancer Institute.

[21]  T. von Zglinicki,et al.  Role of Oxidative Stress in Telomere Length Regulation and Replicative Senescence , 2000, Annals of the New York Academy of Sciences.

[22]  J. Cerhan,et al.  A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  A. Halline,et al.  Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. , 1991, Cancer research.

[24]  T. Chen,et al.  A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D. , 1990, The Journal of nutritional biochemistry.

[25]  S. Manolagas,et al.  1,25-dihydroxyvitamin D3 receptors in human leukocytes. , 1983, Science.

[26]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[27]  R. DePinho,et al.  Telomeres and telomerase in cancer. , 2010, Carcinogenesis.

[28]  B. Hollis,et al.  Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. , 1997, Methods in enzymology.

[29]  T. Chen,et al.  Methods for the determination of the circulating concentration of 25-hydroxyvitamin D. , 1990, The Journal of nutritional biochemistry.

[30]  B. Pence,et al.  Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. , 1988, Carcinogenesis.